Prostate cancer

Author:

Kaprin Andrei D.ORCID,Alekseev Boris Ia.,Matveev Vsevolod B.,Pushkar’ Dmitrii Iu.,Govorov Aleksandr V.ORCID,Gorban’ Nina A.,Kirichek Andrei A.,Biriukov Vitalii A.,Volkova Mariia I.,Gulidov Igor A.,Gumenetskaia Iuliia V.,Krylov Valerii V.,Kariakin Oleg B.,Krasheninnikov Aleksei A.,Mardynskii Iurii S.,Niushko Kirill M.,Zakharova Tatiana I.,Kostin Andrei A.,Khmelevskii Evgenii V.,Fedenko Aleksandr A.,Bolotina Larisa V.ORCID,Falaleeva Natalia A.,Filonenko Elena V.,Nevol’skikh Aleksei A.,Ivanov Sergei A.,Khailova Zhanna V.,Gevorkian Tigran G.

Abstract

Prostate cancer (RPP) is a malignant neoplasm that arises from the epithelium of the prostate gland gland (PJ). рак предстательной железы; клинические рекомендацииThethiology and pathogenesis of this disease remain poorly studied. Many studies are aimed at studying diet, food, hormonal impact, as well as infections in the etiology of the RLPG. The prevalence of RPL depends on ethnic and geographical features. The highest incidence of African Americans living in the United States (60% higher than that of white Americans), the least high - in the Chinese living in China [1]. In addition to racial features, the risk factors of the RPG are considering the genetic predisposition, the age of men and nutritional features. The probability of developing a PJ tumor in a man who has one of the closest relatives of the first degree of kinship (father or brother) sick of the RLPG, is 1.8 times higher than in the population. If two relatives were sick or more (father and brother or both brothers), the risk of RPG increases in 5.51 and 7.71 times, respectively [2, 3]. African Americans have an increased risk of identifying RPG, as well as a greater probability of detecting aggressive RPG [4]. Also, the risk of RLPG is rising in men who use a large amount of animal fats [5].

Publisher

Consilium Medicum

Subject

Cancer Research,Oncology

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3